Dasha Smith
CIK 1794225 · View on SEC EDGAR ↗
Insider
First SEC filing: April 5, 2021 · Latest: April 5, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 24 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 1, 2026 | CNS | A | 353 | — | — | 10,267 Direct | +3.56% | Acquired | (price as of 2026-08-20) |
| July 1, 2025 | CNS | A | 360 | — | — | 8,615 Direct | +4.36% | Acquired | (price as of 2026-08-20) |
| April 1, 2025 | CNS | A | 341 | — | — | 8,255 Direct | +4.31% | Acquired | (price as of 2026-08-20) |
| Jan. 2, 2025 | CNS | A | 298 | — | — | 7,914 Direct | +3.91% | Acquired | (price as of 2026-08-20) |
| Oct. 1, 2024 | CNS | A | 291 | — | — | 7,616 Direct | +3.97% | Acquired | (price as of 2026-08-20) |
| July 1, 2024 | CNS | A | 383 | — | — | 7,325 Direct | +5.52% | Acquired | (price as of 2026-08-20) |
| April 1, 2024 | CNS | A | 362 | — | — | 6,942 Direct | +5.50% | Acquired | (price as of 2026-08-20) |
| Jan. 2, 2024 | CNS | A | 365 | — | — | 6,580 Direct | +5.87% | Acquired | (price as of 2026-08-20) |
| Oct. 2, 2023 | CNS | A | 442 | — | — | 6,215 Direct | +7.66% | Acquired | (price as of 2026-08-20) |
| July 3, 2023 | CNS | A | 472 | — | — | 5,773 Direct | +8.90% | Acquired | (price as of 2026-08-20) |
| April 3, 2023 | CNS | A | 433 | — | — | 5,301 Direct | +8.89% | Acquired | (price as of 2026-08-20) |
| Jan. 3, 2023 | CNS | A | 419 | — | — | 4,868 Direct | +9.42% | Acquired | (price as of 2026-08-20) |
| Oct. 3, 2022 | CNS | A | 432 | — | — | 4,449 Direct | +10.75% | Acquired | (price as of 2026-08-20) |
| July 1, 2022 | CNS | A | 429 | — | — | 4,017 Direct | +11.96% | Acquired | (price as of 2026-08-20) |
| April 1, 2022 | CNS | A | 315 | — | — | 3,588 Direct | +9.62% | Acquired | (price as of 2026-08-20) |
| Jan. 3, 2022 | CNS | A | 298 | — | — | 3,273 Direct | +10.02% | Acquired | (price as of 2026-08-20) |
| Oct. 1, 2021 | CNS | A | 325 | — | — | 2,975 Direct | +12.26% | Acquired | (price as of 2026-08-20) |
| July 1, 2021 | CNS | A | 304 | — | — | 2,650 Direct | +12.96% | Acquired | (price as of 2026-08-20) |
| April 1, 2021 | CNS | A | 375 | — | — | 2,346 Direct | +19.03% | Acquired | (price as of 2026-08-20) |
| Jan. 4, 2021 | CNS | A | 341 | — | — | 1,971 Direct | +20.92% | Acquired | (price as of 2026-08-20) |
| Oct. 1, 2020 | CNS | A | 447 | — | — | 1,630 Direct | +37.79% | Acquired | (price as of 2026-08-20) |
| July 1, 2020 | CNS | A | 366 | — | — | 1,183 Direct | +44.80% | Acquired | (price as of 2026-08-20) |
| April 1, 2020 | CNS | A | 581 | — | — | 817 Direct | +246.19% | Acquired | (price as of 2026-08-20) |
| Jan. 2, 2020 | CNS | A | 236 | — | — | 236 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.